cancer biomarkers, such as cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein, are used as indicators for cancer screening and as predictors for therapeutic responses and prognoses in cancer patient. The trait is Experimental Factor Ontology term EFO_0005127 (cancer biomarker measurement).